← Oncology Approval Tracker

FDA DECISION ·

Bortezomib Injection

bortezomib · Shilpa Medicare

FDA approvalNew formulationMultiple myeloma and mantle cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with multiple myeloma or mantle cell lymphoma; use of the approved liquid bortezomib injection in labeled regimens.

LAMPGEN ANALYSIS

Why it matters

A liquid presentation of this proteasome inhibitor changes pharmacy preparation for established treatment settings.

What research teams should watch

Use product- and route-specific concentration checks to prevent preparation errors when switching between liquid and lyophilized presentations.

PRIMARY RECORDS

Sources